Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Hospital Arnau de Vilanova
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Arnau de Vilanova (33)
2024
-
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Archivos de Bronconeumologia
2023
-
Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study
Frontiers in Psychology, Vol. 14
2022
-
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer
Journal for immunotherapy of cancer, Vol. 10, Núm. 12
-
Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study
Minerva Anestesiologica, Vol. 88, Núm. 4, pp. 259-271
2021
-
Characteristics of isolated superficial vein thrombosis and diagnostic-therapeutic management in spanish hospital emergency departments:The altamira study
Emergencias, Vol. 33, Núm. 6, pp. 433-440
-
Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer
Cancers, Vol. 13, Núm. 14
-
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
npj Breast Cancer, Vol. 7, Núm. 1
-
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420
2020
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
2017
-
18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial
Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441
-
Critically short telomeres and toxicity of chemotherapy in early breast cancer
Oncotarget, Vol. 8, Núm. 13, pp. 21472-21482
-
Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives
Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2
-
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588
-
Role of total tumour load of sentinel lymph node on survival in early breast cancer patients
Breast, Vol. 33, pp. 8-13
2016
-
Endoscopic surveillance in patients with multiple (10-100) colorectal polyps
Endoscopy, Vol. 48, Núm. 1, pp. 56-61
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
2015
-
Febrile young infants with altered urinalysis at low risk for invasive bacterial infection. A Spanish pediatric emergency research network's study
Pediatric Infectious Disease Journal, Vol. 34, Núm. 1, pp. 17-21
-
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations
Leukemia Research Reports, Vol. 4, Núm. 2, pp. 64-69